Zeaxanthin dipalmitate-enriched wolfberry extract improves vision in a mouse model of photoreceptor degeneration

PLoS One. 2024 May 20;19(5):e0302742. doi: 10.1371/journal.pone.0302742. eCollection 2024.

Abstract

Zeaxanthin dipalmitate (ZD) is a chemical extracted from wolfberry that protects degenerated photoreceptors in mouse retina. However, the pure ZD is expensive and hard to produce. In this study, we developed a method to enrich ZD from wolfberry on a production line and examined whether it may also protect the degenerated mouse retina. The ZD-enriched wolfberry extract (ZDE) was extracted from wolfberry by organic solvent method, and the concentration of ZD was identified by HPLC. The adult C57BL/6 mice were treated with ZDE or solvent by daily gavage for 2 weeks, at the end of the first week the animals were intraperitoneally injected with N-methyl-N-nitrosourea to induce photoreceptor degeneration. Then optomotor, electroretinogram, and immunostaining were used to test the visual behavior, retinal light responses, and structure. The final ZDE product contained ~30mg/g ZD, which was over 9 times higher than that from the dry fruit of wolfberry. Feeding degenerated mice with ZDE significantly improved the survival of photoreceptors, enhanced the retinal light responses and the visual acuity. Therefore, our ZDE product successfully alleviated retinal morphological and functional degeneration in mouse retina, which may provide a basis for further animal studies for possible applying ZDE as a supplement to treat degenerated photoreceptor in the clinic.

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Electroretinography
  • Lycium* / chemistry
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Photoreceptor Cells, Vertebrate* / drug effects
  • Photoreceptor Cells, Vertebrate* / pathology
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacology
  • Retina / drug effects
  • Retina / metabolism
  • Retina / pathology
  • Retinal Degeneration* / drug therapy
  • Retinal Degeneration* / pathology
  • Vision, Ocular / drug effects
  • Xanthophylls / pharmacology
  • Zeaxanthins* / pharmacology

Grants and funding

Ningxia Key Research and Development Program Grant (No. 2021BEF02040 to WZ), the Natural Science Foundation of Guangdong Province (2023A1515012397 to YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.